YD BioLabs, Co, Ltd.

YD BioLabs develops enzyme-enabled technologies for precise nucleic-acid modification, rapid DNA/RNA end labeling, dual-labeled probe generation, and antibody–oligonucleotide conjugation (AOC)—with workflows completed in just a few hours.

By integrating enzyme technology, oligonucleotide chemistry, purification, bioconjugation, and molecular-assay development, we turn complex processes into streamlined, ready-to-use workflows for researchers, biotechnology companies, diagnostics developers, and CROs, while building opportunities for future pharmaceutical partnerships.

The company’s theme - “Enzymes Meet Nucleic Acids”—captures its core proposition:

Customers begin with "Unmodified DNA, RNA, siRNA, mRNA, or Antibody input → Site-specific enzymatic modification → Labeling or Conjugation → Easy Spin Column Purification → Functional Probes, conjugates or Research Reagents" in just a few hours!

YD BioLabs' portfolio includes:

- Rapid 3′ and 5′-End ssDNA Labeling & Purification Kits

- Rapid Dual-End ssDNA Labeling & Purification Kits

- Rapid ssRNA 3'-End-Labeling & Purification Kits

- Rapid eOligoLinker Antibody Conjugation and Purification Kits

- Other molecular-biology enzymes.